论文部分内容阅读
查士睿华收购药明康德曾经被国内媒体称为中美之间最大的医药企业并购案,从4月26日俘出水面之后,投资界和媒体褒贬不一。反对呼声不小,暗地运作阻挠交易完成的举措频频出现,直到接近投票决定是否能成交
Charles Schwarzenegger’s acquisition of WuXi PharmaTech was once described by the domestic media as the largest medical enterprise merger between China and the United States. After the water was captured on April 26, the investment community and the media were mixed. Opposition to the call is not small, dark operation obstruct the completion of the transaction appears frequently until close to the vote to decide whether to deal